(2R,3R)-N-[(7R,8R,9E,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(heptylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide

C58H85N7O15S — CID 90206864

IUPAC(2R,3R)-N-[(7R,8R,9E,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(heptylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide
SMILESCCCCCCCSC[C@@]1(O)/C=C\C(=O)NCC(=O)OC[C@@H]2NC(=O)[C@@H]([C@@H](C)O)NC(=O)[C@H](Cc3ccccc3)N(C)C(=O)C(NC(=O)[C@@H]([C@@H](C)CC)NC(=O)[C@@H](NC(=O)[C@H](C)[C@H](O)C(C)C)[C@@H](C)OC2=O)c2ccc(cc2)O[C@@H]1C
InChIInChI=1S/C58H85N7O15S/c1-11-13-14-15-19-28-81-32-58(77)27-26-44(67)59-30-45(68)78-31-42-57(76)79-37(8)48(63-51(70)35(6)50(69)33(3)4)55(74)61-46(34(5)12-2)53(72)64-49(40-22-24-41(25-23-40)80-38(58)9)56(75)65(10)43(29-39-20-17-16-18-21-39)52(71)62-47(36(7)66)54(73)60-42/h16-18,20-27,33-38,42-43,46-50,66,69,77H,11-15,19,28-32H2,1-10H3,(H,59,67)(H,60,73)(H,61,74)(H,62,71)(H,63,70)(H,64,72)/b27-26-/t34-,35+,36+,37+,38+,42-,43-,46+,47+,48-,49?,50+,58-/m0/s1
InChIKeyVQKGIGXNDSYNNS-HHGCCMRJSA-N
MW1152.42 g/mol
LogP2.31
Rot. Bonds17

About (2R,3R)-N-[(7R,8R,9E,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(heptylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide

(2R,3R)-N-[(7R,8R,9E,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(heptylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide (PubChem CID 90206864) has the molecular formula C58H85N7O15S and a molecular weight of 1152.42 g/mol. Its IUPAC name is (2R,3R)-N-[(7R,8R,9E,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(heptylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide.

Molecular Properties

Compound Name(2R,3R)-N-[(7R,8R,9E,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(heptylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide
PubChem CID90206864
Molecular FormulaC58H85N7O15S
Molecular Weight1152.42 g/mol
Exact Mass1151.58
IUPAC Name(2R,3R)-N-[(7R,8R,9E,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(heptylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide
SMILESCCCCCCCSC[C@@]1(O)/C=C\C(=O)NCC(=O)OC[C@@H]2NC(=O)[C@@H]([C@@H](C)O)NC(=O)[C@H](Cc3ccccc3)N(C)C(=O)C(NC(=O)[C@@H]([C@@H](C)CC)NC(=O)[C@@H](NC(=O)[C@H](C)[C@H](O)C(C)C)[C@@H](C)OC2=O)c2ccc(cc2)O[C@@H]1C
InChIInChI=1S/C58H85N7O15S/c1-11-13-14-15-19-28-81-32-58(77)27-26-44(67)59-30-45(68)78-31-42-57(76)79-37(8)48(63-51(70)35(6)50(69)33(3)4)55(74)61-46(34(5)12-2)53(72)64-49(40-22-24-41(25-23-40)80-38(58)9)56(75)65(10)43(29-39-20-17-16-18-21-39)52(71)62-47(36(7)66)54(73)60-42/h16-18,20-27,33-38,42-43,46-50,66,69,77H,11-15,19,28-32H2,1-10H3,(H,59,67)(H,60,73)(H,61,74)(H,62,71)(H,63,70)(H,64,72)/b27-26-/t34-,35+,36+,37+,38+,42-,43-,46+,47+,48-,49?,50+,58-/m0/s1
InChIKeyVQKGIGXNDSYNNS-HHGCCMRJSA-N
XLogP2.31
TPSA317.43 Ų
H-Bond Donors9
H-Bond Acceptors16
Rotatable Bonds17
Heavy Atoms81
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001152.42
LogP ≤ 52.31
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze (2R,3R)-N-[(7R,8R,9E,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(heptylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2R,3R)-N-[(7R,8R,9E,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(heptylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide?
The IUPAC name of (2R,3R)-N-[(7R,8R,9E,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(heptylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide (CID 90206864) is (2R,3R)-N-[(7R,8R,9E,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(heptylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide.
What is the SMILES notation for (2R,3R)-N-[(7R,8R,9E,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(heptylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide?
The canonical SMILES for (2R,3R)-N-[(7R,8R,9E,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(heptylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide is CCCCCCCSC[C@@]1(O)/C=C\C(=O)NCC(=O)OC[C@@H]2NC(=O)[C@@H]([C@@H](C)O)NC(=O)[C@H](Cc3ccccc3)N(C)C(=O)C(NC(=O)[C@@H]([C@@H](C)CC)NC(=O)[C@@H](NC(=O)[C@H](C)[C@H](O)C(C)C)[C@@H](C)OC2=O)c2ccc(cc2)O[C@@H]1C.
What is the InChIKey of (2R,3R)-N-[(7R,8R,9E,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(heptylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide?
The InChIKey is VQKGIGXNDSYNNS-HHGCCMRJSA-N. The full InChI is InChI=1S/C58H85N7O15S/c1-11-13-14-15-19-28-81-32-58(77)27-26-44(67)59-30-45(68)78-31-42-57(76)79-37(8)48(63-51(70)35(6)50(69)33(3)4)55(74)61-46(34(5)12-2)53(72)64-49(40-22-24-41(25-23-40)80-38(58)9)56(75)65(10)43(29-39-20-17-16-18-21-39)52(71)62-47(36(7)66)54(73)60-42/h16-18,20-27,33-38,42-43,46-50,66,69,77H,11-15,19,28-32H2,1-10H3,(H,59,67)(H,60,73)(H,61,74)(H,62,71)(H,63,70)(H,64,72)/b27-26-/t34-,35+,36+,37+,38+,42-,43-,46+,47+,48-,49?,50+,58-/m0/s1.
What are the key properties of (2R,3R)-N-[(7R,8R,9E,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(heptylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide?
(2R,3R)-N-[(7R,8R,9E,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(heptylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide has a molecular weight of 1152.42 g/mol, XLogP of 2.31, 17 rotatable bonds, 9 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for (2R,3R)-N-[(7R,8R,9E,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(heptylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide is sourced from PubChem (CID 90206864), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).